VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.

Gebski, Val; Gibbs, Emma; Gandhi, Mihir; Chatellier, Gilles; Dinut, Aurelia; Pereira, Helena; Chow, Pierce Kh; Vilgrain, Valérie

Gebski, Val; Gibbs, Emma; Gandhi, Mihir; Chatellier, Gilles; Dinut, Aurelia; Pereira, Helena; Chow, Pierce Kh; Vilgrain, Valérie.

Afiliação

Gebski V; NHMRC Clinical Trials Centre, University Sydney, Camperdown, Australia.
Gibbs E; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
Gandhi M; Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore.
Chatellier G; Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.
Dinut A; Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.
Pereira H; Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.
Chow PK; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Vilgrain V; Department of Radiology, Assistance Publique, Hôpitaux de Paris, Paris, France.

JMIR Res Protoc ; 6(2): e17, 2017 Feb 15.

Article em En | MEDLINE | ID: mdl-28202430

Palavras-chave

advanced hepatocellular carcinoma; individual patient data prospective meta-analysis; noninferiority; percentage of active control retained; selective internal radiation therapy; sorafenib

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: JMIR Res Protoc Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália País de publicação: Canadá

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google